Correlation Between Neumora Therapeutics, and SunOpta

Can any of the company-specific risk be diversified away by investing in both Neumora Therapeutics, and SunOpta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neumora Therapeutics, and SunOpta into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neumora Therapeutics, and SunOpta, you can compare the effects of market volatilities on Neumora Therapeutics, and SunOpta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neumora Therapeutics, with a short position of SunOpta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neumora Therapeutics, and SunOpta.

Diversification Opportunities for Neumora Therapeutics, and SunOpta

0.44

Correlation Coefficient

Neumora Therapeutics,  SunOpta

Very weak diversification

The 3 months correlation between Neumora and SunOpta is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, and SunOpta in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SunOpta and Neumora Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neumora Therapeutics, are associated (or correlated) with SunOpta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SunOpta has no effect on the direction of Neumora Therapeutics, i.e., Neumora Therapeutics, and SunOpta go up and down completely randomly.

Pair Corralation between Neumora Therapeutics, and SunOpta

Given the investment horizon of 90 days Neumora Therapeutics, is expected to under-perform the SunOpta. In addition to that, Neumora Therapeutics, is 4.09 times more volatile than SunOpta. It trades about -0.21 of its total potential returns per unit of risk. SunOpta is currently generating about -0.23 per unit of volatility. If you would invest  765.00  in SunOpta on December 29, 2024 and sell it today you would lose (262.00) from holding SunOpta or give up 34.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neumora Therapeutics,  vs.  SunOpta

Neumora Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neumora Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

SunOpta

Risk-Adjusted Performance

Very Weak

Over the last 90 days SunOpta has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Neumora Therapeutics, and SunOpta

The main advantage of trading using opposite Neumora Therapeutics, and SunOpta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neumora Therapeutics, position performs unexpectedly, SunOpta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SunOpta will offset losses from the drop in SunOpta's long position.

The idea behind Neumora Therapeutics, and SunOpta pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.